Vaccines Are a Moving Target, Right?

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

When yo vaccine that is designed to fight one particular variant of avirus andothers, new variants that have arrived. It gets really tricky to pick up all f these reasons that people might have different amun responses,. Different likelihood of exposure and so on. So you can have a sit ation where different vaccines have different mechanisms of protection. Maybe for oxford astrozenics, vaccine, tea cells are playing a more important role in keeping you, especially out of the hospital.

Since the beginning oft he pandemic, researchers have searched for a biomarker which indicates immune protection from COVID-19 known as a correlate of protection. Now, the team developing the Oxford–AstraZeneca COVID-19 vaccine have published the first results of their so-called 'breakthrough study' which indicated puts forwards thresholds of neutralising antibodies that they suggest correlate with protection. The hope is that, should these results be confirmed, such biomarkers could speed up the development of new vaccines, and provide better ways to monitor the efficacy of tweaked vaccine aimed at fighting variants.

News: Scientists identify long-sought marker for COVID vaccine success

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.